Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The effect of youth assertive community treatment: a systematic PRISMA review.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central, [2001-
    • الموضوع:
    • نبذة مختصرة :
      Background: During the past decades deinstitutionalisation policies have led to a transition from inpatient towards community mental health care. Many European countries implement Assertive Community Treatment (ACT) as an alternative for inpatient care for "difficult to reach" children and adolescents with severe mental illness. ACT is a well-organized low-threshold treatment modality; patients are actively approached in their own environment, and efforts are undertaken to strengthen the patient's motivation for treatment. The assumption is that ACT may help to avoid psychiatric hospital admissions, enhance cost-effectiveness, stimulate social participation and support, and reduce stigma. ACT has been extensively investigated in adults with severe mental illness and various reviews support its effectiveness in this patient group. However, to date there is no review available regarding the effectiveness of youth-ACT. It is unknown whether youth-ACT is as effective as it is in adults. This review aims to assess the effects of youth-ACT on severity of psychiatric symptoms, general functioning, and psychiatric hospital admissions.
      Method: A systematic literature search was conducted in PubMed, Cochrane Library, PsychINFO and CINAHL published up to March 2017. To assess methodological quality of the included studies, the Oxford Centre of Evidence-Based Medicine grading system was used.
      Results: Thirteen studies were included in this review. There are indications that youth-ACT is effective in reducing severity of psychiatric symptoms, improving general functioning, and reducing duration and frequency of psychiatric hospital admissions.
      Conclusions: The current literature on youth-ACT is limited but promising. There are indications that youth-ACT is effective in reducing severity of psychiatric symptoms, improving general functioning, and reducing duration and frequency of psychiatric hospital admissions. The effect of youth-ACT may be comparable with the effect of ACT in adults. Similar as in adult ACT, the studies on youth-ACT found effects that vary from small to large. Randomized experimental research designs are needed to further corroborate effectiveness.
    • References:
      Br J Psychiatry. 1988 Jun;152:834-7. (PMID: 3167471)
      Early Interv Psychiatry. 2013 Feb;7(1):94-9. (PMID: 22765257)
      Early Interv Psychiatry. 2008 Aug;2(3):195-200. (PMID: 21352153)
      Psychiatr Serv. 1996 Jul;47(7):757-9. (PMID: 8807692)
      Acta Psychiatr Scand Suppl. 2006;(429):9-16. (PMID: 16445476)
      Aust N Z J Psychiatry. 2001 Jun;35(3):370-6. (PMID: 11437812)
      Am J Orthopsychiatry. 2007 Jul;77(3):350-61. (PMID: 17696663)
      Child Psychiatry Hum Dev. 2015 Dec;46(6):997-1005. (PMID: 25700848)
      Br J Psychiatry. 1999 May;174:413-6. (PMID: 10616607)
      Arch Gen Psychiatry. 2008 Oct;65(10):1125-33. (PMID: 18838629)
      J Rehabil Res Dev. 2007;44(6):813-25. (PMID: 18075939)
      Psychiatr Serv. 2007 Nov;58(11):1486-8. (PMID: 17978262)
      Fam Process. 2016 Sep;55(3):514-28. (PMID: 27370172)
      Soc Psychiatry Psychiatr Epidemiol. 2003 Apr;38(4):165-72. (PMID: 12664226)
      Drug Alcohol Depend. 2010 Jul 1;110(1-2):44-54. (PMID: 20219293)
      Schizophr Bull. 2003;29(4):703-15. (PMID: 14989408)
      Arch Psychiatr Nurs. 2016 Oct;30(5):645-6. (PMID: 27654251)
      Psychiatr Serv. 2009 Jul;60(7):908-13. (PMID: 19564220)
      J Consult Clin Psychol. 2005 Jun;73(3):411-23. (PMID: 15982139)
      Addiction. 2007 Jan;102(1):81-93. (PMID: 17207126)
      PLoS Med. 2009 Jul 21;6(7):e1000097. (PMID: 19621072)
      Psychiatr Serv. 2001 Aug;52(8):1039-45. (PMID: 11474048)
      Psychol Med. 2010 Nov;40(11):1759-65. (PMID: 20624327)
      Psychol Addict Behav. 2014 Mar;28(1):154-62. (PMID: 23276315)
      Psychiatr Serv. 2000 Nov;51(11):1410-21. (PMID: 11058189)
      Clin Child Psychol Psychiatry. 2015 Jul;20(3):458-71. (PMID: 24694901)
      Curr Psychiatry Rep. 2011 Oct;13(5):321-2. (PMID: 21713647)
      Psychiatr Serv. 1999 Jun;50(6):818-24. (PMID: 10375153)
      Br J Psychiatry. 1994 Aug;165(2):179-94. (PMID: 7953031)
      Arch Gen Psychiatry. 1980 Apr;37(4):392-7. (PMID: 7362425)
      J Am Acad Child Adolesc Psychiatry. 2006 Jan;45(1):8-25. (PMID: 16327577)
      Psychiatr Serv. 2006 Feb;57(2):185-96. (PMID: 16452695)
      Am J Orthopsychiatry. 1998 Apr;68(2):216-32. (PMID: 9589760)
      Psychiatr Serv. 1997 Apr;48(4):497-503. (PMID: 9090733)
      Psychiatr Serv. 2011 Jun;62(6):650-8. (PMID: 21632735)
      J Subst Abuse Treat. 2002 Jul;23(1):21-32. (PMID: 12127465)
      Hosp Community Psychiatry. 1988 Apr;39(4):411-8. (PMID: 2836295)
      Child Adolesc Ment Health. 2013 May;18(2):116-119. (PMID: 32847289)
      Clin Psychol Rev. 2014 Aug;34(6):468-81. (PMID: 25047448)
      Arch Gen Psychiatry. 1983 Nov;40(11):1228-31. (PMID: 6639293)
      Asian J Psychiatr. 2015 Aug;16:32-5. (PMID: 26182842)
      Am J Psychiatry. 2007 Mar;164(3):393-9. (PMID: 17329462)
      BMJ. 2004 Jun 19;328(7454):1490. (PMID: 15205295)
      Br J Psychiatry. 1995 May;166(5):654-9. (PMID: 7620753)
      Psychiatry. 2006 Spring;69(1):47-68. (PMID: 16704332)
      J Child Adolesc Psychiatr Nurs. 2012 Feb;25(1):51-2. (PMID: 22299807)
      Psychiatr Serv. 1995 Mar;46(3):233-8. (PMID: 7796208)
      J Consult Clin Psychol. 2014 Feb;82(1):40-51. (PMID: 24294838)
      J Psychoactive Drugs. 1998 Jan-Feb;30(1):81-7. (PMID: 9565211)
      BMJ. 2007 Aug 18;335(7615):336. (PMID: 17631513)
      Community Ment Health J. 2014 Feb;50(2):150-7. (PMID: 23229053)
      Schizophr Bull. 2015 Jan;41(1):30-43. (PMID: 25065017)
      Cochrane Database Syst Rev. 2010 Oct 06;(10):CD007906. (PMID: 20927766)
      Psychiatr Serv. 2012 Mar;63(3):216-22. (PMID: 22388528)
    • Contributed Indexing:
      Keywords: Adolescent; Assertive community treatment; Assertive outreach; Review
    • الموضوع:
      Date Created: 20170804 Date Completed: 20180305 Latest Revision: 20240603
    • الموضوع:
      20240603
    • الرقم المعرف:
      PMC5541424
    • الرقم المعرف:
      10.1186/s12888-017-1446-4
    • الرقم المعرف:
      28768492